[68Ga]Ga-DOTA-Ahx-VGB3

N/A

Report date: 2025/11/20 16:02:49

NME

Base Information

Drug Name[68Ga]Ga-DOTA-Ahx-VGB3

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionVascular endothelial growth factor receptor 2 bindersVascular endothelial growth factor receptor 1 binders

TargetsVascular endothelial growth factor receptor 2Vascular endothelial growth factor receptor 1

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIran

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTehran University Of Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesTehran University Of Medical Sciences

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A